Responsibilities

• Brand Strategy & Portfolio Leadership
• Develop and execute the integrated brand strategy for Navtemadlin to maximize long-term asset value and patient impact.
• Translate portfolio and asset objectives into clear commercial priorities, strategic initiatives, and measurable business outcomes.
• Launch & Growth Execution
• Lead late-stage development commercialization planning and launch readiness activities for a Phase 3 oncology therapeutic, with a strong focus on US market requirements.
• Drive lifecycle management strategies that accelerate growth, expand market opportunities, and sustain brand performance.
• Cross-Functional Leadership
• Lead and influence a global matrix team across Commercial, Medical, Market Access, Regulatory, Finance, Supply Chain, and other key functions.
• Build alignment across global and local stakeholders to ensure effective decision-making and execution.
• Customer & Market Insight

Requirements

• BA/BS (undergraduate degree) in business or life sciences is required
• MBA or advanced degree is preferred.
• 15+ years of experience in the pharmaceutical or biotechnology industry, including global or regional marketing, brand strategy, asset strategy and launch leadership roles.
• Demonstrated late-stage development, pre-launch, and global launch experience, including in the U.S
• Experience in oncology and especially in hematology is preferred.
• Proven track record of developing and executing global brand strategies in collaboration with Medical, Market Access, Regulatory, Development, and Commercial functions.
• Strong understanding of launch readiness, lifecycle management, evidence generation, market access across major markets, and global-to-local execution.
• Demonstrated ability to lead and influence cross-functional, cross-cultural matrix teams with and without direct authority.
• Fluent English is required
• Additional languages e.g., French or other a benefit

Benefits

• We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries.For more information, visit ipsen.com.Pauta exclusiva para México:Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO.